Moreover, abnormal FERMT1 expression has been described in several cancers, including colon cancer [9], gastric cancer [10], oral squamous cell carcinoma [11] and nasopharyngeal carcinoma [12]. This evidence concerns the gene FERMT1 and gastric cancer.